• Channels
    • All News
    • Premium Content
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

BY­OD Best Prac­tices: How Mo­bile De­vice Strat­e­gy Leads to More Pa­tient-Cen­tric Clin­i­cal Tri­als

Last year

Can we cre­ate a world free of pain?

Last year

Start­ing your clin­i­cal jour­ney with the end in mind – the val­ue of a drug de­vel­op­ment plan

Last year

From Clin­i­cal Strat­e­gy to De­vel­op­ment: Nav­i­gat­ing COVID-19 to Sup­port the Next Gen­er­a­tion of Pa­tient-Fo­cused Treat­ments

3 years ago

Top Five Rules for Suc­cess in De­cen­tral­ized Tri­als

3 years ago

Ac­cel­er­at­ing drug de­vel­op­ment with­out sac­ri­fic­ing safe­ty: How phar­ma­covig­i­lance is keep­ing pace with COVID-19 clin­i­cal re­search

3 years ago

Tar­get­ing a Po­ten­tial Vul­ner­a­bil­i­ty of Cer­tain Can­cers with DNA Dam­age Re­sponse

3 years ago

Forg­ing an In­no­v­a­tive Path in CNS Treat­ment

3 years ago

Is Aus­tralia the next Glob­al Des­ti­na­tion for Phase 2?

3 years ago

Vi­da Ven­tures: Pow­er­ing Break­throughs in Bio­phar­ma

3 years ago

Da­ta Lit­er­a­cy: The Foun­da­tion for Mod­ern Tri­al Ex­e­cu­tion

3 years ago

5AM Ven­tures: Fu­el­ing the Next Gen­er­a­tion of In­no­va­tors

3 years ago

I-Mab —A Biotech on the Rise with In­spired Sci­ence

3 years ago

Fos­ter­ing Re­silien­cy at the Cross­roads of Try­ing Times: A Tool­box for Em­ploy­ee Agili­ty

3 years ago

Hair­pins and Scis­sors - De­liv­er­ing a Non-Gene Edit­ed Al­lo­gene­ic CAR T Cell Ther­a­py for the Mass­es

3 years ago

Putting Da­ta to Work in a Pan­dem­ic

3 years ago

Clin­i­cal tri­al mon­i­tor­ing is about to change for­ev­er

3 years ago

Im­ple­ment­ing re­silience in the clin­i­cal tri­al sup­ply chain

3 years ago

Biotech IPOs: New Steps to Suc­cess on the Road to Go­ing Pub­lic

3 years ago

Evolv­ing Treat­ment Land­scape for NASH

3 years ago

How In­no­v­a­tive Tech­nolo­gies and a Ded­i­cat­ed Site Net­work is Dri­ving Pa­tient Re­cruit­ment for Biotech Clin­i­cal Tri­als in Aus­tralia

3 years ago

A new chap­ter in the de­cen­tral­ized clin­i­cal tri­al ap­proach

3 years ago

Solv­ing Phar­ma’s Da­ta Si­lo Prob­lem: Why a Link­able Da­ta In­fra­struc­ture is Good for Bio­phar­ma and Good for Pa­tients

3 years ago

How Clini­cReady by Aus­tralian CRO Avance Clin­i­cal de­liv­ers pre­clin­i­cal project man­age­ment and sci­en­tif­ic and reg­u­la­to­ry ad­vice to get biotechs in­to clin­ic faster

3 years ago
First page Previous page 1234567 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET